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Abstract  13 
Variants in the LIM homeobox transcription factor 1-beta gene (LMX1B) predispose individuals to 14 
elevated intraocular pressure (IOP), a key risk factor for glaucoma. However, the effect of LMX1B 15 
mutations varies widely between individuals. To better understand mechanisms underlying LMX1B-16 
related phenotypes and individual differences, we backcrossed the Lmx1bV265D (also known as 17 
Lmx1bIcst) allele onto the C57BL/6J (B6), 129/Sj (129), C3A/BLiA-Pde6b+/J (C3H), and DBA/2J-Gpnmb+ 18 
(D2-G) mouse strain backgrounds. Strain background had a significant effect on the onset and severity 19 
of ocular phenotypes in Lmx1bV265D/+ mutant mice. Mice of the B6 background were the most 20 
susceptible to developing an abnormal IOP distribution, severe anterior segment developmental 21 
anomalies (including malformed eccentric pupils, iridocorneal strands, and corneal abnormalities) and 22 
glaucomatous nerve damage. In contrast, Lmx1bV265D mice of the 129 background were the most 23 
resistant to developing anterior segment abnormalities, had less severe IOP elevation than B6 mutants 24 
at young ages, and showed no detectable nerve damage. To identify genetic modifiers of susceptibility 25 
to Lmx1bV265D-induced glaucoma-associated phenotypes, we performed a mapping cross between mice 26 
of the B6 (susceptible) and 129 (resistant) backgrounds. We identified a modifier locus on 27 
Chromosome 18, with the 129 allele(s) substantially lessening severity of ocular phenotypes, as 28 
confirmed by congenic analysis. By demonstrating a clear effect of genetic background in modulating 29 
Lmx1b-induced phenotypes, providing a panel of strains with different phenotypic severities, and 30 
identifying a modifier locus, this study lays a foundation for better understanding the roles of LMX1B in 31 
glaucoma with the goal of developing new treatments.  32 
 3 
Introduction  33 
Glaucoma is a group of complex disorders that share a characteristic pattern of visual field deficits and 34 
retinal ganglion cell degeneration. It is a leading cause of blindness worldwide affecting 80 million 35 
people (Quigley and Broman, 2006). Important risk factors for glaucoma include elevated intraocular 36 
pressure (IOP), genetics, and advanced age. Lowering IOP to a safe level is the only available 37 
treatment (Weinreb et al., 2014). The aqueous humor (AqH) drainage tissues, including the Schlemm’s 38 
canal (SC) and trabecular meshwork (TM), have a key role in controlling IOP (Fautsch and Johnson, 39 
2006). Resistance to AqH drainage from the eye through the SC and TM is important in determining 40 
IOP. However, the mechanisms underlying dysfunctional AqH drainage and subsequent IOP elevation 41 
require additional characterization. A majority of glaucoma cases are attributed to primary open angle 42 
glaucoma (POAG), where IOP elevation lacks an obvious physical cause (Quigley and Broman, 2006). 43 
Recently, genome wide association studies (GWAS) have improved understanding of the genetic basis 44 
of POAG by implicating more than 70 loci (Bonnemaijer et al., 2018; Choquet et al., 2018; Choquet et 45 
al., 2020; Genetics of Glaucoma in People of African Descent et al., 2019; Khawaja et al., 2018; 46 
MacGregor et al., 2018; Taylor et al., 2019; Youngblood et al., 2019). Research that defines how these 47 
genes affect IOP is expected to yield new drug targets and improved treatments for lowering IOP 48 
(Choquet et al., 2020).      49 
The LIM homeobox transcription factor 1-beta (LMX1B) gene was associated with elevated IOP and 50 
POAG through genome wide association studies (GWAS) and has been validated in multiple 51 
populations (Choquet et al., 2018; Gao et al., 2018; Gharahkhani et al., 2018; Khawaja et al., 2018; 52 
MacGregor et al., 2018; Shiga et al., 2018). Prior to GWAS, dominant mutations in LMX1B were 53 
identified to cause nail-patella syndrome (NPS) (Chen et al., 1998; Dreyer et al., 1998; Vollrath et al., 54 
1998). NPS is a developmental disorder with characteristic symptoms including nail dysplasia and 55 
abnormally developed limb structures (Farley et al., 1999; Sweeney et al., 2003). Within NPS patients, 56 
20-30% develop elevated IOP and POAG, a prevalence that is significantly higher than in the general 57 
population (Mimiwati et al., 2006; Sweeney et al., 2003). Apart from POAG, there are a wide range of 58 
ocular phenotypes reported in NPS patients including developmental iris, corneal, and pupillary 59 
abnormalities and congenital glaucoma (Lichter et al., 1997; Sawamura et al., 2014; Spitalny and 60 
Fenske, 1970). Importantly, there are striking differences in onset and severity of phenotypes between 61 
patients that inherit the same LMX1B variant (Knoers et al., 2000; McIntosh et al., 2005; Sweeney et 62 
al., 2003). Thus, it is likely that genetic background modulates the risk of developing specific disease 63 
phenotypes in patients with LMX1B variants. Identifying genetic modifiers of LMX1B-related 64 
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phenotypes will be important in understanding risk of glaucoma and is expected to provide novel 65 
mechanistic information on the etiology of IOP elevation. 66 
Based on high sequence homology, mice have been used to understand the biological role of LMX1B 67 
in several tissues (McIntosh et al., 2005). Previous work in mice has shown that LMX1B is required for 68 
the development and function of AqH drainage tissue including the TM (Liu and Johnson, 2010; 69 
Pressman et al., 2000). Mice with dominant point mutations in Lmx1b recapitulate several phenotypes 70 
found in humans with LMX1B variants. One important mutation causes a valine to aspartic acid 71 
substitution (Lmx1bV265D, also known as Lmx1bIcst) in the transcription factor’s homeodomain, disrupting 72 
its ability to bind DNA (Cross et al., 2014). Mice heterozygous for Lmx1bV265D/+ develop elevated IOP 73 
and glaucomatous neurodegeneration (Cross et al., 2014). Previous reports show Lmx1b heterozygous 74 
null alleles do not cause glaucoma in mice (Cross et al., 2014; Pressman et al., 2000). Importantly, the 75 
Lmx1bV265D allele is dominant negative and causes a different range and severity of abnormal 76 
phenotypes compared to a heterozygous null allele (Cross et al., 2014). Lmx1bV265D mice present with 77 
several additional ocular phenotypes including abnormal SC and TM, congenital defects of the iris such 78 
as iridocorneal strands, abnormally open pupils, and corneal phenotypes including corneal opacities, 79 
corneal neovascularization, and corneal scarring (Cross et al., 2014). Congenital abnormalities of the 80 
iris, cornea, and pupil have also been observed in a subset of NPS patients (Beals and Eckhardt, 1969; 81 
Bennett et al., 1973; Lichter et al., 1997; Spitalny and Fenske, 1970; Sweeney et al., 2003). Based on 82 
these phenotypic similarities, Lmx1bV265D mutant mice are a valuable model for determining 83 
mechanisms and modifiers of ocular disease phenotypes that may affect humans with LMX1B variants.  84 
 
Given the phenotypic variation between individuals with the same LMX1B variant (McIntosh et al., 85 
2005), we expected to find differences in glaucoma-associated ocular phenotypes between different 86 
genetically diverse mouse strains with the Lmx1bV265D allele. Here, we characterized the ocular effects 87 
of the Lmx1bV265D allele on four different mouse strain backgrounds. Our results show that strain 88 
background significantly affects the onset and progression of glaucoma-related phenotypes in 89 
Lmx1bV265D/+ mice including IOP elevation and glaucomatous neurodegeneration. Based on this, we 90 
performed a gene mapping experiment between the most susceptible and resistant strain backgrounds 91 
and identified a modifier locus on Chromosome 18. 92 
 
Materials and Methods  93 
Animal husbandry and ethics statement 94 
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The Lmx1bV265D mutation was discovered in an ENU mutagenesis screen (Cross et al., 2014; Thaung et 95 
al., 2002). It is formally named the Icst (iridocorneal strands) allele, but we refer to it based on the 96 
protein level change V265D. Briefly, ENU-mutagenized Balb/cAnN (MRC Harwell, Oxfordshire, UK) 97 
were crossed to C3H/HeN mice (MRC Harwell, Oxfordshire, UK), and their offspring were screened 98 
(Thaung et al., 2002). Mice carrying the Icst mutation were crossed to C57BL/6J for gene mapping, and 99 
sequencing of the Lmx1b gene identified the V265D mutation (Cross et al., 2014; Thaung et al., 2002). 100 
These mice were then backcrossed to the C57BL/6J (Stock# 000664), DBA/2J-Gpnmb+/SjJ (Stock# 101 
007048), C3A/BLiA-Pde6b+/J (Stock# 001912) and 129/Sj (Stock# 003884) for 8-10 generations. To 102 
determine if a tyrosinase deficient background exacerbated phenotypic severity, Lmx1bV265D was also 103 
backcrossed to the BALB/cJ (Stock# 000651) background for 6-8 generations and mice analyzed at 3 104 
to 6 months of age. All experimental mice were backcrossed at least 6 generations. The 129/Sj strain 105 
was created from mice carrying a heterozygous knockout mutation generated in TL1 ES cells and 106 
maintained on a 129S6/SvEvTac background. We obtained this strain and selected mice without the 107 
heterozygous knockout mutation for inbreeding. Genotyping evidence suggests our 129/Sj strain 108 
contains large regions aligning to both 129S6/SvEvTac and 129S1/SvImJ respectively but is genetically 109 
distinct to any other 129 substrains (data not shown).  DBA/2J, C3A/BLiA-Pde6b+/J, and 129/Sj mice 110 
were maintained on NIH 31 (6% fat) diet. To avoid obesity, C57BL/6J (B6) mice were maintained on 111 
NIH 31 diet (4% fat) diet and HCl acidified water (pH 2.8-3.2). Early studies showed that the minor 112 
difference in fat content did not affect the phenotypes. Mutant and control littermates were housed 113 
together with Alpha-dri bedding in cages covered with polyester filters. Cages were maintained in an 114 
environment kept at 21°C with a 14-hour light: 10-hour dark cycle. All mice were treated in accordance 115 
with the Association for Research in Vision and Ophthalmology’s statement on the use of animals in 116 
ophthalmic research. The Institutional Animal Care and Use Committee of The Jackson Laboratory 117 
approved all experimental protocols.  118 
Genotyping of the Lmx1b allele 119 
Lmx1bV265D and Lmx1b+ genotypes were determined using an allele-specific PCR protocol. Genomic 120 
DNA was PCR amplified with forward primer specific to the V265D allele 5'-121 
TCAGCGTGCGTGTGGTCCTGGA-3', a forward primer specific to the wild type allele 5'-122 
GACATTGGCAGCAGAGACAGGCCGAGGCGTGCGTGTGGTCCATGT-3', and the reverse primer 5'-123 
ACACAAGCCTCTGCCTCCTT-3'. Genomic DNA was PCR amplified using the following program; 1) 124 
95oC for 2 minutes, 2) 95oC for 15 seconds, 3) 57 oC for 20 seconds, 4) 72 oC for 30 seconds, 5) repeat 125 
steps 2-4 35 times, 6) 72oC for seven minutes. 5 μl of sample was run on a 3% agarose gel. The wild 126 
type allele amplifies a 175 base pair fragment and the V265D allele amplifies a 152 base pair fragment. 127 
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Although we used these primers in this study, mismatches exist in some of them compared to reference 128 
sequence. We have subsequently confirmed that they provided accurate genotypes compared to 129 
Sanger sequencing. Reference matched primer sequences are 5'-TCAGCGTGCGTGTGGTCCAGGA-130 
3' (V265D forward primer), 5'- GACATTGGCAGCAGAGACAGGCCTCAGCGTGCGTGTGGTCCAGGT-131 
3' (wild type forward primer), and 5'-ACACAAGGCTCTGCCTCCTT-3' (reverse primer). 132 
Quantitative PCR (qPCR) 133 
RNA was isolated from ocular anterior segment tissues (except the lens) of B6, D2, and 129 inbred 134 
strains at 4 months of age (2 eyes pooled per sample). RNA was isolated using the RNeasy Mini Kit 135 
(Qiagen) according to the manufacturer’s protocols. Total RNA was reverse transcribed using the high 136 
capacity cDNA Reverse Transcription kit (Applied Biosystems). Relative mRNA levels were determined 137 
by using the SYBRTM Green PCR Master Mix (Applied Biosystems) according to the manufacturer’s 138 
instructions. For each reaction 400ng (anterior segment) of total RNA was used as input for reverse 139 
transcription, and 10ng of cDNA was used for qPCR. Primers used for Lmx1b were forward 5’ 140 
GAGCAAAGATGAAGAAGCTGGC 3’ and reverse 5’ CTCCATGCGGCTTGACAGAA 3’ [previously 141 
published in (Wever et al., 2019)]. Primers for Gapdh were forward 5’ 142 
CGACTTCAACAGCAACTCCCACTCTTCC 3’ and reverse 5’ 143 
TGGGTGGTCCAGGGTTTCTTACTCCTT 3’. Quantitative PCR (qPCR) data was analyzed using the 144 
delta-delta Ct method. Results were statistically analyzed using Student’s t-test. Graphs represent the 145 
fold change relative to B6 background expression (n= 3 for each strain). 146 
Slit-lamp examination 147 
Anterior eye tissues were examined approximately every 3 months between 2-13 months of age using 148 
a slit-lamp biomicroscope and photographed with a 40x objective lens. Phenotypic evaluation included 149 
iris structure, pupillary abnormalities, generalized corneal haze, corneal opacity, corneal keratopathy, 150 
hyphaema, hypopyon, corneal pyogenic granuloma, vascularized scarred cornea, buphthalmos, 151 
cataracts, and deepening of the anterior chamber. A subset of phenotypes that were common in 152 
Lmx1bV265D/+ mice (anterior chamber deepening, pupillary abnormalities, corneal haze, and corneal 153 
opacity) were characterized and graded based on a semiquantitative scale of either phenotype being 154 
not present, mild, moderate, or severe in presentation (Table 1). Detailed examination of typically 40 155 
eyes from each strain and genotype at 4, 7, and 11 months of age was performed, except for the C3H 156 
background at 7 months where 12 mutant eyes and 14 WT eyes were examined. C3H mice at 4 157 
months were examined but no phenotypes were graded. We found no sex difference in onset and 158 
severity of the phenotypes. Therefore, we combined both sexes in our analyses, with all cohorts 159 
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including balanced numbers of male and female mice. Groups were compared pairwise by Fisher’s 160 
exact test. 161 
IOP measurement 162 
IOP was measured using the microneedle method as previously described in detail (John et al., 1997; 163 
Savinova et al., 2001). Briefly, mice were acclimatized to the procedure room and anesthetized via an 164 
intraperitoneal injection of a mixture of ketamine (99 mg/kg; Ketlar, Parke-Davis, Paramus, NJ) and 165 
xylazine (9 mg/kg; Rompun, Phoenix Pharmaceutical, St. Joseph, MO) immediately prior to IOP 166 
assessment, a procedure that does not alter IOP in the experimental window (Savinova et al., 2001). 167 
IOP values were grouped by mouse age. IOPs measured at 3 to 5.9 months of age were grouped into 168 
the young timepoint (3-6mo), 6 to 8.9 months were grouped into the intermediate timepoint (6-9mo), 169 
and mice 9 to 11.9 months were grouped into the older timepoint (9-12mo). Lmx1bV265D/+ and WT IOP 170 
distributions did not meet the assumption of equal variance by Levene’s test. Therefore, we compared 171 
individual groups by two-tailed Welch’s t-test. In mice, IOP elevation caused by different mutations 172 
(including mutations in human glaucoma genes) is often accompanied by both an upward and a 173 
downward spread of values. This is due to complex effects including ocular stretching, perturbations of 174 
diurnal regulation and ciliary body dysfunction or atrophy (Chang et al., 2001; John et al., 1998). This 175 
spreading effect was strong in our current study and especially so for the V265D allele (likely 176 
exacerbated by their weakened/ expandable corneas and corneal ulceration with perforation in some 177 
mice - see text). Thus, to examine the magnitude of IOP dysregulation in Lmx1bV265D/+ eyes, we used 178 
the absolute value of the difference from the WT mean of each measurement (calculated by subtracting 179 
each mutant or WT value from the WT mean of the matching strain background and age). Distributions 180 
of these values were plotted and, as they also failed the assumption of equal variance between groups, 181 
were compared statistically by two-tailed Welch’s t-test. To further visualize the change in variance 182 
between Lmx1bV265D/+ and WT groups, we binned IOP values into four categories (<10mmHg, 10-183 
19.9mmHg, 20-29.9 mmHg, and ≥30mmHg). The percentage of IOP values within each category was 184 
compared across experimental groups by Fisher’s exact test. We measured IOP of at least 30 eyes per 185 
group (age, genotype, and strain background) except for C3H background mice at 6-8 months where 186 
n= 20 mutant and 13 WT. All cohorts included balanced number of male and female mice. During each 187 
IOP measurement period, eyes of independent wild-type B6 mice were assessed in parallel with 188 
experimental mice as a methodological control to ensure proper calibration and equipment function.  189 
Ocular histological analysis 190 
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Enucleated eyes were fixed for plastic sectioning (0.8% paraformaldehyde and 1.2% glutaraldehyde in 191 
0.08 M phosphate buffer (pH 7.4) as previously described in detail (John et al., 1998). Serial sagittal 192 
sections were collected, stained with hematoxylin and eosin, and analyzed for pathologic alterations at 193 
3 months of age. For analysis of angle morphology relevant to drainage function, we used a previously 194 
validated grading scheme to determine the degree of angle closure due to adhesions/malformations 195 
that block drainage (Libby et al., 2003). The lower the total score the more extensively an angle is open 196 
around the circumference of any eye, while the higher the score the more closed it is. Briefly, we 197 
evaluated 24 similarly spaced angle regions from of each eye including the peripheral, mid-peripheral, 198 
and central ocular regions. For a few WT eyes, only 15 to 22 angle locations were scored due to 199 
regional processing artifacts. Angle scores for such eyes were normalized to the others for direct 200 
comparison. Each angle was graded based on the extent of angle blockage by attachment of  the iris to 201 
the trabecular meshwork and cornea as previously reported (Libby et al., 2003) (0 = normal, iris and 202 
ciliary body join at iris root with no adhesion to the TM or cornea, 1 = iris attached to very posterior 203 
portion of TM so that most of the TM/angle is open and accessible for drainage, 2 = iris attached to TM 204 
for up to three quarters of the extent of TM, 3 = iris covers entire TM and extends just into peripheral 205 
cornea indicating a completely closed angle region, 4 = iris covers TM and adhesion extends further 206 
onto cornea). The final angle score is the sum of values for each angle location. The minimum possible 207 
score is 0, reflecting a completely normal, fully-open angle at all locations. A score of 24, would indicate 208 
that either the angle is completely open for at least 75% of the assessed circumference with minor 209 
abnormalities in the remaining 20%, or that an angle is open for even more of its circumference with 210 
focal occurrence or more severe abnormalities. The maximum score is 96 (4 X 24) reflects a completely 211 
closed angle at all locations with extensive attachment of the iris to the peripheral cornea. A score of 72 212 
(3 x 24) also reflects a completely closed angle as the iris completely covers the TM at all assessed 213 
locations in such eyes. The samples were intermixed, and the observers were not aware of the Lmx1b 214 
genotype or genetic background during the grading. Two observers, masked to sample identity as well 215 
as each other, graded the eyes. The score assigned by each observer agreed >96% of the time and 216 
never disagreed by more than 1 grade. Disagreements involved regions with abnormalities at the 217 
border of two grades and differences were resolved by consensus agreement when still masked to 218 
sample identity. The summed grade of all the examined angles from each mouse is plotted. Because 219 
the data was discretized, groups were statistically compared by Mann-Whitney U test. Each group 220 
contained balanced numbers of male and female mice. We analyzed 5-7 eyes, with a median of 6 eyes 221 
of each genotype for both the 129 and B6 strains. 222 
Optic nerve assessment 223 
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Intracranial portions of optic nerves were dissected, processed, and analyzed as previously described 224 
(Howell et al., 2007; Howell et al., 2012; Nair et al., 2016; Williams et al., 2017). Briefly, optic nerve 225 
cross-sections were stained with para-phenylenediamine (PPD) and examined for glaucomatous 226 
damage. PPD stains all myelin sheaths of a healthy axon, but differentially darkly stains the myelin 227 
sheaths and the axoplasm of sick or dying axons. This allows for the sensitive detection and 228 
quantification of axon damage and loss. Optic nerves were prepared for analysis with a 48h fixation in 229 
0.8% paraformaldehyde and 1.2% glutaraldehyde in 0.08M phosphate buffer (pH 7.4) at 4oC followed 230 
by overnight treatment in osmium tetroxide at 4oC. Nerves were washed twice for 10 minutes on 0.1 M 231 
phosphate buffer, once in 0.1 M sodium-acetate buffer and dehydrated in graded ethanol 232 
concentrations. Tissues were then embedded in Embed 812 resin (Electron Microscopy Sciences, Ft. 233 
Washington, PA), and 1-μm thick sections were stained in 1% PPD for approximately 40 minutes. 234 
Stained sections were compared using a previously reported grading scale that is validated against 235 
axon counting (Howell et al., 2007; Howell et al., 2012). All cohorts included balanced numbers of male 236 
and female mice. We analyzed approximately 30 nerves for each strain and genotype, except for strain 237 
129 WT and D2-G mutant groups where we graded 15 and 17 nerves per group respectively. Groups 238 
were compared pairwise by Fisher’s exact test.  239 
Gene mapping and QTL analysis 240 
To identify loci controlling strain differences in phenotype onset and severity, Lmx1b+/+ males of the 241 
glaucoma-susceptible B6 background were crossed to glaucoma-resistant 129.Lmx1bV265D/+ female 242 
mice. 129B6F1 Lmx1bV265D/+ mice were screened for anterior eye phenotypes by slit-lamp between 1-6 243 
months. 129B6F1 mice were resistant to Lmx1b’s effects, indicating that a dominant 129 locus(i) 244 
contributes to phenotypic resistance. To characterize this locus(i), we backcrossed 129B6F1 245 
Lmx1bV265D/+ mice of both sexes to the B6 background to create an N2 recombinant mapping cohort. A 246 
total of 107 N2 Lmx1bV265D/+ progeny of both sexes were aged and screened by slit-lamp and IOP 247 
measurement between 1-3 months and 4-5 months. We used slit-lamp data to map the genomic loci 248 
contributing to resistance. Based on slit-lamp data, each mapping mouse was binned into one of three 249 
categories; bilateral susceptible (B6-like), bilateral resistant (129-like), or unilateral. Mice were 250 
considered bilateral susceptible if one or more of the following phenotypes was at least moderate or 251 
severe in each eye; anterior chamber depth, pupil open, corneal haze, corneal opacity. If neither eye 252 
had any moderate or severe ocular phenotypes, mice were considered bilateral resistant. Due to 253 
variable expressivity, several mice had unilateral phenotypes affecting only the left or right eye in a 254 
random fashion. Genotyping was performed using 138 regularly spaced genome-wide single nucleotide 255 
polymorphic markers that differentiate the B6 and 129 genomes (SNPs, KBioscience, UK). We 256 
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performed a genome-wide one-dimensional quantitative trait locus (QTL) scan to identify the 257 
chromosomal loci modulating Lmx1b phenotypes. r/QTL version 1.14-2 was used for QTL analysis 258 
(Broman et al., 2003). The final QTL analysis uses mouse sex as an additive covariate and calculates 259 
genotype probability between SNP markers. QTL intervals were based on a 1.5 LOD drop from the 260 
maximum LOD peak on the chromosome. Because the first marker we genotyped on Chr 18 was at 5 261 
Mb, we did not examine recombinants between 0-5 Mb. All genomic coordinates were calculated using 262 
GRCm38 (mm10) assembly. 263 
Congenic strain generation and phenotyping 264 
The implicated Chr 18 modifier locus from strain 129 was backcrossed onto the B6 strain. This locus 265 
was selected using the slit-lamp based, phenotype severity data for 4-5 months old mice. At each 266 
generation of backcrossing, we used 5 markers to ensure transfer of the Chr 18 interval and flanking 267 
sequences (D18MIT19, D18MIT88, D18MIT123, D18MIT185, and D18Jmp6) to strain B6. After 10 or 268 
more generations, mice heterozygous (B6/129) at each of these Chr18 markers were crossed to 269 
B6.Lmx1bV265D/+ mice to generate our experimental cohort and all experimental mice heterozygous for 270 
the modifier region were confirmed to have strain 129 alleles throughout the 69.5 Mb region. Mice were 271 
assessed by slit-lamp at 1-6 months of age and binned using the same bailateral susceptible, bilateral 272 
resistant, and unilateral groupings as for the N2 mapping mice. All groups contained balanced numbers 273 
of males and females and were compared by Fisher’s exact test. 274 
 
Results 275 
Strain 129 background is most resistant while B6 background is most susceptible 276 
Strain background had a profound effect on the ocular phenotypes in Lmx1bV265D/+ mice (Fig. 1). Rare 277 
abnormal phenotypes were detected in some WT mice. This is due to the previously documented 278 
susceptibility of B6 mice to developmental abnormalities including anterior segment dysgenesis and 279 
anophthalmia (Chase, 1942; Gould and John, 2002; Smith et al., 1994). The frequency of these 280 
abnormalities varies based on factors such as environmental stress, and alcohol exposure (Cook et al., 281 
1987; Sulik et al., 1981; Webster et al., 1983). Ocular disease phenotypes in Lmx1bV265D/+ mutants 282 
included deepened anterior chambers, malformed and eccentric pupils, iridocorneal strands (strands of 283 
iris focally fused to cornea), corneal haze, corneal vascularization, corneal scleralization, and corneal 284 
ulceration (Fig. 1). We compared group differences in the frequency and severity of ocular phenotypes 285 
using Fisher’s exact test. Of all examined strain backgrounds, 129.Lmx1bV265D/+ mice were most 286 
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resistant to developing these abnormal ocular phenotypes (Fig. 1). When present in strain 129 mutants, 287 
phenotypes were generally mild (Figs 1,2). Overall, B6 mutants had the most developmentally severe 288 
phenotypic abnormalities of all backgrounds. Compared to D2-G mutants, B6 mutants develop more 289 
severe anterior chamber deepening at young ages (3-5 months) and more severe corneal haze at all 290 
ages (all P < 0.01, Fig. 2). C3H and B6 mutants were similar in phenotype severity across ages, except 291 
for corneal haze, which was significantly more severe in B6 mutants at young and intermediate ages (6-292 
8 months; P < 0.01, Fig. 2). Therefore, overall B6.Lmx1bV265D/+ are the most susceptible, C3H and D2-G 293 
backgrounds are intermediate, while strain 129 is the most resistant. 294 
 295 
To test if the phenotypic differences are impacted by strain-dependent functional changes in the WT 296 
Lmx1b locus, we examined the Lmx1b locus of all four inbred strains using sequence data available 297 
from the Sanger Mouse Genomes Project (Keane et al., 2011). As 129/Sj and C3A/BLiA-Pde6b+/J were 298 
not available in the database, we used three closely related substrains of 129 (129P2/OlaHsd, 299 
129S1/SvlmJ, and 129S5SvEvBrd) and the closely related C3H/HeJ substrain respectively as proxies 300 
for the strain 129 and C3H genotypes. Compared to the B6 reference genome, neither the 129 nor C3H 301 
substrains have any coding regions or intergenic variants in conserved regions that would affect 302 
function. In contrast, the D2 background contains 3’ UTR variants, synonymous coding variants, and a 303 
predicted splice region variant (rs27178126) 8bp from the splice donor site in intron 3. However, 304 
transcriptomic data from D2-G background limbal tissue showed no splicing abnormalities of any 305 
Lmx1b exons (data not shown). Given this, and the facts that 1) WT D2-G mice lack haploinsufficient 306 
Lmx1b phenotypes and 2) Lmx1bV265D/+ D2-G mice are phenotypically similar to heterozygotes on the 307 
others strains and lack lethal homozygous mutant phenotypes, we conclude that the splice-region 308 
change has no effect. Additionally, as our most susceptible and resistant strains have identical Lmx1b 309 
loci, there is no clear relationship between the strain-specific WT Lmx1b locus and phenotypic severity. 310 
Furthermore, there are no changes in endogenous Lmx1b expression levels in ocular anterior segment 311 
tissue between wild type mice of the susceptible (B6) and resistant (129) inbred strains (Fig. S1). This 312 
indicates that other genetic modifier(s) underlie the observed phenotypic differences between these 313 
strains.  314 
B6.Lmx1bV265D/+ mice have the most severely affected drainage structures 315 
Structural abnormalities in the aqueous humor drainage structures, Schlemm’s canal (SC) and 316 
trabecular meshwork (TM), can lead to glaucoma by impacting IOP. These structures are located within 317 
the iridocorneal angle that runs around the entire limbal circumference of the eye. To evaluate whether 318 
strain background impacted drainage structure abnormalities in Lmx1bV265D/+ mice, we analyzed the 319 
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morphology of the iridocorneal angle of our most extreme strains B6 and 129. WT mice have open 320 
drainage angles and normal SC and TM morphology (Fig. 3A). We found a spectrum of abnormalities in 321 
Lmx1bV265D/+ mice of both B6 and 129 backgrounds including malformed or absent SC and/or TM as 322 
well as iridocorneal angle adhesions. Such abnormalities are expected to result in physical obstructions 323 
to aqueous humor outflow (closed angle; Fig. 3A). The effect on outflow will depend on the extent of 324 
such abnormalities around the eye, but outflow measurements were not performed. The severity of 325 
abnormalities in mutant mice varies both between eyes and locally around the angle circumference 326 
within individual eyes (Fig. 3A). Importantly, angle abnormalities were more severe in B6 background 327 
mutants compared to those of the 129 background (Mann-Whitney U Test, P = 0.0023; Fig. 3B). 328 
Despite open-angle regions, B6 mutant angles were closed to aqueous humor drainage around much 329 
of the ocular circumference. However, strain 129 mutant angles were largely open and typically had 330 
only mild abnormalities. Mild iridocorneal angle abnormalities have been reported in patients with 331 
LMX1B variants and POAG (Lichter et al., 1997; Vollrath et al., 1998) 332 
IOP distribution is abnormal in Lmx1bV265D/+ mice of all backgrounds with B6 being most severe 333 
at young ages. 334 
We longitudinally examined IOP in WT and Lmx1bV265D/+ eyes and found an overall change to the 335 
distribution of IOP values in Lmx1bV265D/+ eyes compared to WT controls. Spreading of IOP in both 336 
directions can be caused by various factors including ciliary body atrophy/malformation and corneal 337 
damage, as is most common in the Lmx1b B6 mutants here. Across all strain backgrounds and ages, 338 
mutant eyes had both the highest and lowest IOP values (Fig. 4A-C). The variance of WT and mutant 339 
IOP distributions was significantly different at all examined ages in B6, C3H, and D2-G backgrounds 340 
(Levene’s test, all P < 0.01). We found significantly elevated IOP in C3H (6-9 months), D2-G (3-6 and 341 
6-9 months), and strain 129 (3-6 and 6-9 months) mutants compared to WT controls (Fig. 4A,B; 342 
Welch’s t-test, all P < 0.01). Although IOP was clearly high in some eyes, the spreading of values in 343 
both directions masked the ability to detect mean differences compared to WT controls for other mutant 344 
groups. At 3-6 months, B6 mutants have a larger average dispersion (absolute difference from WT 345 
mean, see Methods) than D2-G and strain 129 mutants (Welch’s t-test, all P < 0.01; Fig. 4D). 346 
Consistent with this, 10% of B6 mutant eyes had IOP >30mmHg at 3-6 months, a magnitude not found 347 
in age-matched WT or mutant eyes of any other background (Fig. S2). C3H mutants did not have IOP 348 
assessed during the 3-6 months age window but appeared similar to B6 in anterior chamber 349 
deepening, a reflection of raised IOP. Although IOP abnormalities were detected in strain 129 mutants 350 
at different ages, there was significantly less IOP dispersion in these mice at advanced ages (9-12 351 
months) compared to all other backgrounds (Welch’s t-test, all P < 0.01; Fig. 4F). Overall, our data 352 
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shows that Lmx1bV265D has a strong impact on IOP with the most extreme and earliest phenotypes on a 353 
B6 background. 354 
B6.Lmx1bV265D/+ mice develop severe glaucoma but 129.Lmx1bV265D/+ mice do not 355 
To assess the extent to which IOP elevation leads to glaucomatous neurodegeneration across genetic 356 
backgrounds, we histologically assessed retinas and optic nerves of Lmx1bV265D/+ and WT mice. 357 
Because the majority of abnormally elevated IOP values are found at 3-6 and 6-9 months in 358 
B6.Lmx1bV265D/+ mice, we examined their optic nerves between 10-12 months. Optic nerves of D2-G 359 
and 129 backgrounds were examined slightly later in life (12-14 months). Consistent with other ocular 360 
phenotypes, B6.Lmx1bV265D/+ mice had the highest prevalence of severely degenerated optic nerves 361 
with nearly 80% of nerves having severe axon loss and damage and prominent gliosis (Fig. 5A,B). 362 
Importantly, mutants on the 129 background did not develop any detectable optic nerve degeneration 363 
(Fig. 5A), even at the oldest age examined. Mutants with optic nerve degeneration had characteristic 364 
hallmarks of glaucoma with retinal nerve fiber layer thinning (layer containing retinal ganglion cell 365 
axons) and optic nerve excavation/remodeling (Fig. 5C).  366 
The BALB background does not increase disease severity  367 
Mutation of the tyrosinase gene (Tyr) increases susceptibility to ocular drainage tissue defects in 368 
Cyp1b1 and Foxc1 mutants (Libby et al., 2003). To assess the effect of an additional genetic 369 
background and if Lmx1b-induced disease onset is earlier in a Tyr deficient background, we crossed 370 
the Lmx1bV265D/+ allele to the albino BALB/cJ (BALB) strain background and analyzed 3 to 6 months old 371 
mice (Yokoyama et al., 1990). Compared to our most susceptible B6 background, BALB mutant mice 372 
are resistant to Lmx1b-induced anterior segment developmental phenotypes (Fig. S3, Table S1). 373 
Similar to strain 129 mutants, anterior segment phenotypes in BALB mutants were generally mild when 374 
present. BALB mutants did develop elevated IOP with their IOP distribution being similar to the other 375 
backgrounds (Fig. S3, Table S2). Therefore, Tyr genotype did not exacerbate disease severity in 376 
Lmx1b mutants on a BALB background.  377 
A locus on Chromosome 18 determines differential susceptibility to Lmx1b-associated 378 
phenotypes  379 
In order to identify genomic regions contributing to differential susceptibility between the B6 and 129 380 
genetic backgrounds, we performed a mapping cross. Specifically, F1 progeny were generated using 381 
males from the susceptible B6 background and Lmx1bV265D/+ females from the more resistant 129 382 
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background. 129B6 Lmx1bV265D/+ F1’s phenocopied 129 mutants indicating 129-dominant loci confer 383 
disease resistance (data not shown). Thus, we backcrossed F1’s to B6 to generate N2 mutant mapping 384 
progeny. Based on the severity of ocular phenotypes as assessed by slit-lamp at each examined age, 385 
N2 Lmx1bV265D/+ mice were binned into a bilateral susceptible (B6-like), bilateral resistant (129-like), or 386 
unilateral categories. The unilateral category was used when only a single eye displayed severe 387 
abnormalities and reflects reduced susceptibility to Lmx1bV265D/+-induced phenotypes. All N2 mapping 388 
progeny were genotyped using single nucleotide polymorphic (SNP) marker analysis. Using this data, 389 
we performed a quantitative trait locus (QTL) scan in our N2 cohort against ocular phenotype severity. 390 
In 1 to 3 months old mice, we detected intervals on Chromosomes 1 (33-139 Mb, max LOD at 53.6 Mb) 391 
and 18 (5-71.7 Mb, max LOD at 30.9 Mb) that significantly associated with slit-lamp based phenotype 392 
severity using a genome-wide significance cutoff (Fig. 6A). At 4 to 5 months, however, only the interval 393 
on chromosome 18 (5-74.5 Mb, max LOD at 30.9 Mb) reached genome-wide significance using the slit-394 
lamp based phenotype severity data (Fig. 6B). To test whether the Chr 18 locus is sufficient to generate 395 
resistance to disease phenotypes in Lmx1b mutants, we backcrossed the strain 129 Chr 18 interval 396 
onto the B6 background. B6.Lmx1bV265D/+ mice that were heterozygous B6/129 throughout the Chr 18 397 
interval were significantly more resistant to the Lmx1b-induced slit-lamp phenotypes than littermates 398 
that were homozygous B6 (Fisher’s exact test, P=0.036; Fig. 6C). This further supports the resistance 399 




Differing disease presentation between individuals 402 
Recent GWAS studies indicate that LMX1B variants cause elevated IOP and glaucoma in the general 403 
human population, without evident anterior segment abnormalities, involvement of other organs/tissues, 404 
or NPS diagnosis (Choquet et al., 2018; Gao et al., 2018; Gharahkhani et al., 2018; Khawaja et al., 405 
2018; MacGregor et al., 2018; Shiga et al., 2018). Similarly, LMX1B mutations cause organ specific 406 
kidney disease without extrarenal involvement (Boyer et al., 2013; Isojima et al., 2014). Several factors 407 
may contribute to differing disease presentations between individuals including the nature of the 408 
LMX1B variant, genetic modifiers, and environmental factors. Here, we clearly show that genetic 409 
background has a strong influence on disease presentation. This effect of genetic background allows a 410 
path to deciphering key pathogenic mechanisms through characterization of modifier genes. 411 
Additionally, this effect must be considered when interpreting experimental data. For example, previous 412 
studies report that mice heterozygous for a null allele of Lmx1b have normal eyes on both a C57BL/6J 413 
and a C57BL/6x129/Sv mixed background respectively (Cross et al., 2014; Pressman et al., 2000). 414 
 15 
Haploinsufficiency is generally accepted to contribute to human disease, as heterozygous deletions 415 
including LMX1B are pathogenic (Bongers et al., 2008; McIntosh et al., 1998). Thus, it remains unclear 416 
if mice differ to humans in their sensitivity to haploinsufficiency-induced phenotypes or if null alleles will 417 
induce characteristic abnormalities when assessed on further genetic backgrounds.  418 
 
The nature of the mutation in Lmx1b is important to consider. The pathogenic nature of LMX1B 419 
haploinsufficiency suggests reduced transcription factor dosage or activity causes disease. However, 420 
as demonstrated by the Lmx1bV265D allele, different mechanisms apart from haploinsufficiency can 421 
contribute to glaucoma such as dominant negative effects (Cross et al., 2014). The location of the point 422 
mutation within human LMX1B correlates with disease severity in the kidney (Bongers et al., 2005). 423 
Additional functional characterization of LMX1B mutations is required to better understand how the 424 
nature of the LMX1B variant affects disease onset and severity. Recently, a dominant stop codon 425 
mutation (Lmx1bQ105X, reported as Lmx1bQ82X) was shown to cause IOP elevation and glaucoma 426 
without anterior segment developmental abnormalities (by slit-lamp) on the D2-G background (Choquet 427 
et al., 2018). This contrasts to the Lmx1bV265D allele, which induces obvious anterior segment 428 
abnormalities on the same D2-G genetic background (Figs 1-3). Together, these data strengthen the 429 
suggestion that the nature of individual LMX1B alleles affects the range and severity of disease 430 
outcomes in human patients (Bongers et al., 2005; McIntosh et al., 1998). Characterizing different 431 
mutant alleles on genetically diverse backgrounds will be important in determining disease mechanisms 432 
and discovering genetic modifiers, with the goal of improving risk assessment and developing 433 
therapeutics (Jeanne and Gould, 2017). 434 
 
Mechanisms of IOP elevation 435 
LMX1B variants are known to disrupt drainage structure development and cause developmental and 436 
juvenile onset glaucoma (Lichter et al., 1997; Liu and Johnson, 2010; Pressman et al., 2000; 437 
Sawamura et al., 2014). These developmental changes lead to drainage structure abnormalities and 438 
IOP elevation. Our data clearly show that all Lmx1bV265D/+ eyes have structural abnormalities of their 439 
iridocorneal angle. B6 mutants had the greatest severity of angle abnormalities and the most severely 440 
dysregulated IOPs at younger ages. This suggests that developmental drainage structure abnormalities 441 
are important in IOP elevation in these mice. Future work is required to determine how these structural 442 
deficits impact resistance to AqH drainage. 129.Lmx1bV265D/+ mice have milder iridocorneal angle 443 
structural abnormalities with the vast majority of the angle being open, but they still develop elevated 444 
IOP. Mild iridocorneal angle defects are found in POAG patients with NPS, which is caused by LMX1B 445 
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variants (Lichter et al., 1997; Vollrath et al., 1998). Thus, strain 129 mutants are a valuable resource to 446 
model IOP elevation in POAG due to LMX1B variants.  447 
 
Although structural developmental changes cause early-onset elevated IOP in some mutants, IOP 448 
becomes high at older ages in other Lmx1b mutants. As mutant eyes have less functional drainage 449 
tissue to begin with, the remaining functional tissue may be more susceptible to damage with age, 450 
leading to later-onset IOP elevation. It is possible that mechanisms unrelated to structure or normal 451 
drainage-function are involved in Lmx1b-phenotypes during development or adult life (Gould et al., 452 
2004). Mutants may have abnormal metabolism or suboptimal defense mechanisms against ongoing 453 
stressors (e.g. oxidative stress) leading to tissue demise and IOP elevation over time. In agreement 454 
with this, the majority of patients with LMX1B variants have primary open angle glaucoma (Sweeney et 455 
al., 2003). These patients develop IOP elevation at older ages and have an open drainage angle with 456 
no obvious structural abnormalities. The mechanisms by which LMX1B variants impact the function of 457 
drainage tissue in POAG are likely complex and require additional characterization. In the current 458 
study, we did not explore whether the Lmx1bV265D mutation directly impacts retinal development or 459 
retinal ganglion cell degeneration. Studies in zebrafish show that Lmx1b orthologues Lmx1b.1 and 460 
Lmx1b.2 are necessary for normal retinal patterning including ventral optic cup morphogenesis 461 
(McMahon et al., 2009). Arguing against a key effect on retinal development in Lmx1bV265D mice, 462 
previous work found no retinal or optic nerve abnormalities in 90% of mice at 8 months of age (Cross et 463 
al., 2014). By 10-11 months, however, >60% of the nerves had developed severe degeneration, 464 
indicating that glaucomatous nerve damage is age related in these Lmx1b mutants (Cross et al., 2014). 465 
In the current study, Lmx1b mutants on strain backgrounds with the most severe incidence of anterior 466 
chamber deepening (a symptom of IOP elevation) and the most abnormal IOP distributions have the 467 
highest incidence of neurodegeneration. Together, these data suggest that IOP elevation is a primary 468 
factor driving neurodegeneration. Still, it remains possible that the Lmx1bV265D mutation sensitizes 469 
retinal cells to degeneration and further experiments are needed to test this. 470 
 
In addition to IOP elevation, abnormally low IOP was found in Lmx1bV265D/+ mice on each strain 471 
background at various ages. Abnormally low IOP is observed in other mouse models with abnormal 472 
anterior segment development (Chang et al., 2001). One contributing factor could be dysgenesis of the 473 
ciliary body, which produces AqH (Chang et al., 2001). Lmx1b is expressed in the developing ciliary 474 
body (Pressman et al., 2000), and the Lmx1bV265D allele could potentially cause dysfunction of AqH 475 
production. Additionally, the Lmx1bV265D allele induces severe corneal phenotypes involving extensive 476 
stretching, ulceration, and perforation, that contribute to lower than normal IOP. B6.Lmx1bV265D/+ mice 477 
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have the highest incidence of abnormally low IOP values and the most severely affected corneas, 478 
consistent with a role of corneal phenotypes in lowering IOP. 479 
 
Identifying the genetic modifiers  480 
The genetic loci that modify glaucoma susceptibility in individuals with LMX1B variants are not known. 481 
The interactions between these loci are likely complex. We discovered QTL on Chromosomes 1 and 18 482 
that predispose Lmx1bV265D/+ mice to severe ocular abnormalities. Future work is required to 483 
characterize specific modifiers, to understand disease risk of individuals with LMX1B mutations, and 484 
provide molecular targets for therapies to treat IOP elevation and glaucoma. Future studies are also 485 
required to directly test QTL impacting IOP, outflow facility, and axon counts in Lmx1b mutant mice. 486 
Although the Chr 1 locus may be important, its effect was only evident at the youngest analyzed age. 487 
We chose to conduct follow up experiments on the Chr 18 locus because it had an effect at both 488 
assessed ages. As the 69.5 megabase interval on Chr 18 contains approximately 442 protein-coding 489 
genes, we are currently unable to nominate specific candidates responsible for strain-specific 490 
differences in susceptibility, limiting our ability to pursue the underlying mechanisms. Ongoing work is 491 
aimed at prioritizing positional candidates. Based on published literature, 5 of the 442 genes are 492 
associated with human glaucoma, elevating them as candidate genes within the interval. However, 493 
none of the 5 corresponding mouse loci have SNPs between B6 and 129 mice that are predicted to 494 
impact transcript abundance or protein function [Table S3; (Keane et al., 2011)]. Regarding genetic 495 
differences between strains B6 and 129, an interval around the Zinc finger E-box-binding homeobox 1 496 
(ZEB1) locus harbors several variants, including predicted functional variants in ZEB1 (Keane et al., 497 
2011). Interestingly, ZEB1 variants cause Fuch’s corneal endothelial dystrophy (FCED) (Gupta et al., 498 
2015). In FCED, the corneal endothelial structure is disrupted causing corneal haze. Corneal haze 499 
differs significantly between B6 and strain 129 Lmx1b mutant mice at each examined age. Furthermore, 500 
Zeb1 null mouse embryos have ocular developmental defects similar to Lmx1b mutants including 501 
iridocorneal adhesions (Liu et al., 2008). However, no links are yet established between ZEB1 and IOP 502 
elevation or LMX1B. Therefore, although ZEB1 is an intriguing candidate, the modifier interval requires 503 
further refinement before a specific locus can be identified. In conclusion, this study lays a strong 504 
foundation for better understanding mechanisms by which LMX1B contributes to glaucoma and for 505 
characterizing new therapeutic targets. 506 
Acknowledgements 507 
 18 
The Authors would like to thank the Histology Services and Computational Services at The Jackson 508 
Laboratory, animal care staff at The Jackson laboratory and Columbia University, and Amy Bell for 509 
intraocular pressure measurements.  510 
 
Funding 511 
EY011721 (SWMJ), Barbara and Joseph Cohen Foundation Precision Medicine Initiative at Columbia 512 
University (SWMJ), unrestricted departmental funds from research to prevent blindness and core grant 513 
P30EY019007 (SWMJ). UK Medical Research Council to MRC Human Genetics Unit, programme 514 
MC_PC_U12756112 (IJJ), EY027004 (KSN), EY022891 (KSN), G2019360 (KSN), EY028175 (KK), 515 
T32HD007065 (NGT). Simon John is an investigator of HHMI.  516 
 
Conflict of interest statement 517 
















Barbara and Joseph Foundation separate  
Precision  
 19 
Figures/Tables:  519 







Normal AC visible by slit-lamp with normal, just-detectable gap between cornea and iris 
Mild AC visible by slit-lamp side view as clear but thin gap between cornea and iris 
Moderate 
AC visible by slit-lamp side view with a 
prominent gap between cornea and iris 
Severe Clearly detectable buphthalmous by naked eye 
Pupil 
abnormalities 
Normal Pupil is centered in iris, circular, and 0.3mm (+/- 0.1mm) diameter 
Mild Pupil is eccentric or mis-shaped, not centered in iris, and/or is up to 2X wider than normal diameter 
Moderate As above, but more severely misshaped and/or up to 4X normal diameter 




Cornea completely transparent 
Mild Transparency of cornea is slightly disrupted (can clearly visualize iris and lens) 
Moderate Transparency of cornea is significantly impacted (difficult to visualize iris and lens)   





Normal No vascularization, scarring, or ulceration present 
Mild Small focal point in cornea with vascularization, scarring, and/or ulcer 
Moderate Obvious vascularization, scarring, and/or ulcer covering up to 50% of cornea 
Severe Vascularization, scarring, and/or ulcer covering more than 50% of cornea 





Figure 1: Strain background alters phenotypes in Lmx1bV265D/+ mice. Representative front and 523 
side-view, slit-lamp images for mice of the indicated ages and genotypes. The frequencies of specific 524 
disease features are shown in Figure 2. WT mice of all backgrounds were similar and so only B6 WTs 525 
are shown. B6.Lmx1bV265D/+ mutant mice have the most severe overall phenotypes including malformed 526 
eccentric pupils, extensive corneal haze and greatly deepened anterior chambers at 3 months of age. 527 
With age, the severity of B6 phenotypes increases, with development of corneal scarring, 528 
vascularization, and ulcers. C3H mutants are generally similar to B6 but are more resistant to 529 
developmental corneal phenotypes at younger ages. D2-G mutants are generally similar to C3H, but 530 
more resistant to LMX1B-induced corneal phenotypes at all ages (see Figure 2). The 129 strain 531 
background is the most resistant, with mutants typically displaying only mild pupillary abnormalities and 532 




Figure 2: B6 background is most susceptible, while strain 129 is most resistant. (A) At 3-5 535 
months, B6 mice have the most severe anterior chamber deepening (ACD), even compared to D2-G 536 
mutants (P = 0.0034). Strain 129 mutants rarely develop abnormal ACD at any age. Anterior chamber 537 
deepening (ACD) is a symptom of IOP elevation. (B-D) The same was true for corneal haze, pupillary 538 
and corneal abnormalities. * P < 0.01; ** P < 1.0E-05; *** P < 1.0E-10 (see supplementary table 1 for 539 




Figure 3: 129.Lmx1bV265D/+ mutants are resistant to angle abnormalities compared to B6. (A) 542 
Representative images of the iridocorneal angle region (H&E stained sagittal sections) in 3 months old 543 
mice. WT mice of both B6 and 129 backgrounds have normal open-angle morphology. Narrow iris 544 
processes (IP), are known to occur intermittently around the angle of WT mice without obstructing 545 
aqueous humor drainage. SC: Schlemm’s canal, black asterisk: trabecular meshwork, CB: ciliary body. 546 
In mutant eyes, abnormalities, including severe iridocorneal adhesions (arrows) as well as absent 547 
(white asterisk) or hypomorphic SC and TM, are locally present within individual eyes (middle panels) 548 
with different locations within the same eyes having open-angles of normal morphology (bottom 549 
panels). Scale bar = 200μm. (B) B6 mutant have high angle scores (Methods), indicating largely closed 550 
or malformed angles. Strain 129 mutants have less severely affected, largely open-angles. Higher 551 
angle scores indicate a more severely and more extensively affected angle around its circumference. A 552 
score of 96 represents a severely abnormal angle at all locations while an angle with a score of 0 being 553 
is completely normal and open at all locations. The strain 129 median grade of 31 indicates that their 554 
angles were open at most locations around the eye. It is established that a small incidence of 555 
developmental abnormalities occurs in B6 WT mice (see main text). Boxplots show interquartile range 556 
and median line. Mann-Whitney U test; * = P < 0.01 (129 vs B6 mutants, P = 0.0023; 129 WT vs mutant 557 
 23 
P = 0.0055; B6 WT vs mutant, P = 0.0033). We examined 5 eyes from the strain 129 WT group, 6 eyes 558 











Figure 4: IOP in Lmx1b mutants (A-C) Boxplots of IOP (interquartile range and median line) clearly 561 
indicate spreading of IOP in mutants of all strain backgrounds with clear IOP elevation in some 562 
mutants. (A-B) Lmx1bV265D/+ mutants of D2-G and strain 129 backgrounds have significantly elevated 563 
IOP compared to respective WT controls at 3-6 mo and 6-9 mo. C3H mutants have elevated IOP at 6-9 564 
months compared to WT controls (P = 0.0032). Although IOP was not measured, anterior chamber 565 
deepening suggests IOP is elevated in many C3H mutants prior to 6 months age (Figure 1) (C) Due to 566 
an increase in abnormally low IOP values, B6.Lmx1bV265D/+ mice have a significantly lower IOP average 567 
than WT controls at 9-11 months old (P = 8.2E-7). (D-F) Boxplots of IOP deviation (absolute value of 568 
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difference to respective WT mean value, Methods) At all ages, WT groups had minimal IOP deviation, 569 
with no values deviating more than 7mmHg. (D) At 3-5 months, B6 mutants have a significantly greater 570 
IOP deviation compared to those of D2-G (P = 0.0068) and strain 129 (P = 4.5E-05) backgrounds. (E-571 
F) Strain 129 mutants have significantly less IOP deviation compared to B6 and C3H mutants at 6-9 572 
months and to all other backgrounds 9-12 months. * P < 0.01, ** P < 0.001, *** P < 0.0001 (see 573 











Figure 5: B6.Lmx1bV265D/+ mice develop glaucomatous neurodegeneration while 129.Lmx1bV265D/+ 576 
mice do not. (A) Frequency histogram of degree of optic nerve damage evident in PPD stained cross 577 
sections (Methods) ** P < 1.0E-05, *** P < 1.0E-10. (B) Representative images of PPD-stained optic 578 
nerve cross sections from Lmx1bV265D/+ mice. (Top) Healthy nerves at 10 months old had no detectable 579 
axonal damage. These axons had a clear axoplasm and darkly stained myelin sheaths. (Middle) 580 
Moderate optic nerve degeneration with some axon loss and early gliosis. (Bottom) Severe damage 581 
and extreme axon loss with extensive glial scarring. Scale bar = 50μm (C) H&E stained optic nerve 582 
heads with flanking retina. WT eyes have normal nerve heads with a thick nerve fiber layer 583 
(arrowheads) as do unaffected mutants. Severely affected mutants have pronounced optic nerve 584 




Figure 6: Modifier loci. Based on slit-lamp data, individual N2 mice were binned into one of three 587 
categories; bilateral susceptible (B6-like), bilateral resistant (129-like), or unilateral. Using this data, a 588 
genome-wide one-dimensional quantitative trait locus (QTL) scan was performed. (A) At 1-3 months, 589 
intervals on both Chr 1 (33-139 Mb, max LOD at 53.6 Mb) and Chr 18 (5-71.7 Mb, max LOD at 30.9 590 
Mb) reached genome wide significance (5% significance threshold, genome-wide corrected, red dotted 591 
line). (B) At 4-5 months, an interval on Chr18 (5-74.5 Mb, max LOD at 30.9 Mb) with the same max 592 
LOD as 1-3 months was identified at genome wide significance. (C) Testing of the modifier locus by 593 
comparing Lmx1bV265D/+ mutant mice that are either homozygous (B6/B6) or heterozygous (B6/129) for 594 
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the Chr 18 intervals. Having a strain 129 genotype throughout the modifier interval significantly 595 
increased resistance to severe ocular phenotypes compared to B6 homozygous littermates (Fisher’s 596 
exact test, P = 0.036). Lmx1b WT mice that are B6/129 heterozygous for the Chr 18 interval did not 597 
develop anterior eye phenotypes (data not shown). We examined 15 (Chr 18 B6/B6) and 18 (Chr 18 598 
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